Find clinical trials for Non-Hodgkin Lymphoma in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Durham, NC, USA:
This study has 2 parts.The main aim of Part 1 is to check for side effects from TAK-007 in adults with relapsed or refractory (r/r) B-cell Non...
Phase 2
Durham, North Carolina, United States and 14 other locations
This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical a...
Phase 1
Durham, North Carolina, United States and 20 other locations
evaluate the efficacy, safety, and tolerability BGB-3111 plus obinutuzumab versus obinutuzumab alone in participants with relapsed/refractory non...
Phase 2
Durham, North Carolina, United States and 83 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Durham, North Carolina, United States and 55 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) ma...
Phase 1
Durham, North Carolina, United States and 20 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....
Phase 3
Chapel Hill, North Carolina, United States and 138 other locations
The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...
Phase 3
Durham, North Carolina, United States and 145 other locations
safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with relapsed and/or refractory diffuse large B cell lymphoma...
Phase 2
Durham, North Carolina, United States and 22 other locations
The study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and r...
Phase 1
Chapel Hill, North Carolina, United States and 7 other locations
This study aims to evaluate the safety, tolerability, pharmacodynamic, and pharmacokinetic (PK) of nemtabrutinib (formerly ARQ 531) tablets in select...
Phase 1, Phase 2
Durham, North Carolina, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal